Who to call at OncoNano Medicine, and when
Fundz watches for the moments OncoNano Medicine starts buying, and tells you who to reach.
- An alert the day OncoNano Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OncoNano Medicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OncoNano Medicine. With Fundz connected, it knows.
OncoNano Medicine and Gilead Sciences Enter Research Collaboration for ON-BOARD™ Technology on Gilead’s Drug Candidate.
Contract Type
partnership
Description
OncoNano Medicine has announced a research collaboration with Gilead Sciences to evaluate the effectiveness of its ON-BOARD™ delivery technology with Gilead's drug candidate. The agreement includes opportunities for milestone payments and royalties based on the success of the collaboration.
Quick answer
OncoNano Medicine and Gilead Sciences Enter Research Collaboration for ON-BOARD™ Technology on Gilead’s Drug Candidate. (January 6, 2026). OncoNano Medicine is based in Southlake, Texas, United States.
- What agreement did OncoNano Medicine announce on January 6, 2026?
- OncoNano Medicine has announced a research collaboration with Gilead Sciences to evaluate the effectiveness of its ON-BOARD™ delivery technology with Gilead's drug candidate. The agreement includes opportunities for milestone payments and royalties based on the success of the collaboration.
- What does OncoNano Medicine do?
- OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics.
- Where is OncoNano Medicine based?
- OncoNano Medicine is based in Southlake, Texas, United States.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansOncoNano Medicine signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.